Financial Overview
M.Cap: ₹11.6 Cr
P/E
27.6
Book Value
₹19.5
ROCE
7.18%
ROE
4.33%
High/Low
₹30.0/N/A
Div Yield
0.00%
Qtrly Sales
₹ 5.47 Cr
Qtrly OPM
24.50%
Qtrly Net Profit
₹ 0.56 Cr
Strengths
- Company has reduced debt.
- Stock is trading at 1.17 times its book value
- Debtor days have improved from 79.1 to 39.5 days.
- Company's working capital requirements have reduced from 55.1 days to 39.3 days
Weaknesses
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 6.60% over past five years.
- Promoter holding is low: 27.5%
- Company has a low return on equity of 6.42% over last 3 years.
Auth. Capital
₹10 Cr
Paid-Up Capital
₹5.07 Cr
Company Details
| Legal Name | BERYL DRUGS LIMITED |
|---|---|
| Incorporation | August 24, 1993 |
| Category | Public / Company limited by shares |
| ROC | ROC Gwalior |
| Registration | 007840 |
| Address | 133 KANCHAN BAGH,INDORE,Indore,Madhya Pradesh,452001-India |